What Does Novo Nordisk Do?

Total employees65715
HeadquartersBagsværd
Founded1923

Novo Nordisk is a global healthcare company with nearly 100 years of innovation and leadership in diabetes care. Building on this heritage, Novo Nordisk is also driving change to defeat obesity, rare blood disorders, and rare endocrine disorders. Headquartered in Denmark, Novo Nordisk employs approximately 64,300 people in 80 offices and markets its products in around 170 countries. Their purpose is to drive change to defeat serious chronic diseases, built upon their heritage in diabetes.

Where Is Novo Nordisk's Headquarters?

HQ Function

Serves as the central hub for global operations, research and development leadership, corporate strategy, and administrative functions.

Notable Features:

The campus, partly designed by Henning Larsen Architects, features modern, interconnected buildings, advanced research labs, and extensive green spaces. It emphasizes Scandinavian design principles, sustainability (e.g., low-energy consumption buildings), and employee well-being with amenities like fitness centers and canteens.

Work Culture:

Characterized by a strong emphasis on scientific innovation, patient-centricity, collaboration, and a commitment to sustainability and social responsibility. It fosters a diverse and inclusive environment with a focus on work-life balance and continuous learning.

HQ Significance:

The Bagsværd headquarters is pivotal as the birthplace of many of Novo Nordisk's groundbreaking treatments and represents the company's long-standing commitment to Denmark and its leadership in the global pharmaceutical industry.

Values Reflected in HQ: The headquarters' design, operations, and focus on cutting-edge research reflect Novo Nordisk's core values of innovation, patient-centricity, sustainability, and responsibility towards employees and the environment.

Location:

Novo Nordisk operates globally, supporting functions such as research and development, manufacturing, commercial operations, clinical trials, regulatory affairs, and patient support programs. The company has offices in 80 countries and its products are marketed in approximately 170 countries worldwide, reflecting its extensive reach in addressing chronic diseases.

Street Address:

Novo Allé 1

City:

Bagsværd

State/Province:

Capital Region of Denmark

Country:

Denmark

Where Else Does Novo Nordisk Operate Around the World?

Plainsboro, New Jersey/USA

Address: 800 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

Drives Novo Nordisk's strategy and presence in the United States, focusing on delivering innovative medicines to patients and engaging with healthcare stakeholders in this major market.

Seattle, Washington/USA

Address: 530 Fairview Ave N, Seattle, WA 98109, USA

Leverages the vibrant biotech ecosystem in Seattle to advance scientific discovery and innovation for new therapeutic targets and drug candidates.

Beijing/China

Address: Novo Nordisk Research & Development Center, No. 20 Life Science Park Road, Changping District, Beijing, China

Strengthens Novo Nordisk's R&D capabilities in Asia and addresses specific healthcare challenges in China, a rapidly growing market for the company.

Buying Intent Signals for Novo Nordisk

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Novo Nordisk? Meet the Executive Team

As of April 2025, Novo Nordisk' leadership includes:

Lars Fruergaard Jørgensen - President and Chief Executive Officer (CEO)
Karsten Munk Knudsen - Executive Vice President and Chief Financial Officer (CFO)
Martin Holst Lange - Executive Vice President, Development
Camilla Sylvest - Executive Vice President, Commercial Strategy & Corporate Affairs
Marcus Schindler - Executive Vice President, Research & Early Development and Chief Scientific Officer
Natalia Miao - Executive Vice President, International Operations
Henrik Wulff - Executive Vice President, Product Supply, Quality & IT

Who's Investing in Novo Nordisk?

Novo Nordisk has been backed by several prominent investors over the years, including:

Novo Holdings A/S (majority shareholder, owned by the Novo Nordisk Foundation)
Capital Research Global Investors
The Vanguard Group
BlackRock, Inc.

What Leadership Changes Has Novo Nordisk Seen Recently?

Hire1
Exits1

In the past year, Novo Nordisk announced a key leadership transition within its International Operations, promoting Natalia Miao to Executive Vice President, succeeding Maziar Mike Doustdar who moved to an advisory role before his planned retirement.

Departures

Maziar Mike Doustdar, Maziar Mike Doustdar transitioned from his role as EVP, International Operations on the Executive Management team to an executive advisor role, ahead of his retirement.

New Appointments:

Natalia Miao, Natalia Miao was appointed to Executive Vice President, International Operations, joining the Executive Management team following her promotion from SVP & President, Region China.

What Technology (Tech Stack) Is Used byNovo Nordisk?

Discover the tools Novo Nordisk uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Novo Nordisk Email Formats and Examples

Novo Nordisk primarily utilizes a few common email formats for its employees globally. The most prevalent patterns include using the employee's first initial followed by their last name, or their full first name separated by a period from their last name, followed by '@novonordisk.com'.

Common formats include [first_initial][last_name]@novonordisk.com (e.g., jdoe@novonordisk.com) and [first_name].[last_name]@novonordisk.com (e.g., jane.doe@novonordisk.com).

Format

jdoe@novonordisk.com

Example

85%

Success rate

What's the Latest News About Novo Nordisk?

Novo Nordisk Press ReleaseMay 24, 2024

Novo Nordisk to invest USD 4.1 billion to expand US production, boosting supply of current and future injectable medicines

Novo Nordisk announced a USD 4.1 billion (DKK 28 billion) investment to build a second fill and finishing manufacturing facility in Clayton, North Carolina, US. This expansion aims to increase manufacturing capacity for current and future injectable treatments for diabetes and obesity, including its GLP-1 products....more

Novo Nordisk Press ReleaseMay 2, 2024

Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at CER in the first three months of 2024

In the first three months of 2024, Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates (CER) to DKK 65.3 billion. Sales growth was driven by both Diabetes and Obesity care, with North America Operations and International Operations contributing significantly....more

Fierce PharmaApril 11, 2024

Novo Nordisk inks potential $1B-plus deal for two cardiometabolic disease candidates from German biotech

Novo Nordisk entered into a collaboration and license agreement with German biotech Cardior Pharmaceuticals to develop and commercialize Cardior’s lead compound CDR132L, targeting heart failure. The deal includes an upfront payment and potential milestone payments exceeding $1 billion....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Novo Nordisk, are just a search away.